Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | AMGN | GILD | CELG | ILMN |
| Company | Protagonist Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 45.08 | 333.93 | 83.37 | 108.01 | 130.19 |
| High | 46.36 | 339.00 | 84.52 | 108.59 | 134.94 |
| Low | 44.40 | 331.00 | 82.76 | 107.27 | 129.69 |
| Last | 44.77 | 332.92 | 83.89 | 108.24 | 130.97 |
| Change | -0.14 | +0.12 | +0.84 | +0.11 | +0.76 |
| % Change | -0.31% | +0.04% | +1.01% | +0.10% | +0.58% |
| Volume | 526,197 | 1,366,586 | 9,198,570 | 191,230,496 | 2,220,040 |
| 20-Day Average Volume | 567,490 | 1,736,279 | 6,437,974 | 16,188,930 | 1,375,052 |
| Previous Close | 44.91 | 332.80 | 83.05 | 108.13 | 130.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 43.30 | 329.25 | 79.63 | 108.17 | 129.11 |
| 20-Day Raw Stochastic | 55.94% | 69.60% | 90.09% | 63.25% | 71.16% |
| 20-Day Relative Strength | 61.44% | 55.28% | 71.85% | 64.69% | 56.96% |
| Weighted Alpha | +157.77 | +25.51 | +18.22 | +46.30 | +4.70 |
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | 100% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | 100% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 40% Buy | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.04% since 09/11/24 | +0.89% since 09/11/24 | +3.64% since 09/11/24 | -1.97% since 11/13/19 | +4.92% since 09/11/24 |
| Low | 44.40 on 09/18/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 120.51 on 09/12/24 |
| High | 48.00 on 09/16/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.53 on 11/14/19 | 134.94 on 09/18/24 |
| 1-Month | |||||
| %Chg | +8.14% since 08/16/24 | +3.57% since 08/16/24 | +13.70% since 08/16/24 | +5.14% since 10/18/19 | +0.51% since 08/16/24 |
| Low | 40.67 on 09/03/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 48.00 on 09/16/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | +37.37% since 06/18/24 | +8.80% since 06/18/24 | +32.84% since 06/18/24 | +13.63% since 08/20/19 | +21.16% since 06/18/24 |
| Low | 30.67 on 06/26/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 48.00 on 09/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +57.31% since 03/18/24 | +22.89% since 03/18/24 | +14.51% since 03/18/24 | +14.14% since 05/20/19 | +0.64% since 03/18/24 |
| Low | 24.22 on 04/26/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 48.00 on 09/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,634,061 | 178,525,568 | 103,468,096 | 77,035,920 | 20,742,456 |
| Shares Outstanding, K | 58,652 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 60,000,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -78,960,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 4,170,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -30,620,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | 2.17 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 08/06/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 17.63 | 18.02 | 17.69 | 10.99 | 140.78 |